Deals, data capture and financial clearing

It's really hard to price drugs  – especially the combination therapies increasingly used. We are creating a new kind of exchange that allow parties to confidentially express contingent commitments which trigger binding agreements and smart contracts when relevant conditions are met. This exchange will allow payers and pharma to safely negotiate the differential pricing and other complex market access deals that can vastly increase access to medicines while providing financial compensation for innovation.

We're building three interconnected modules to allow market access deals to happen as smoothly as possible and get innovative drugs to those who need them:

The Contingent Commitment Facility is the core of our platform; it is the secure workspace that allow parties to confidentially express contingent commitments which trigger binding agreements when the conditions are met. 

The Data Capture Facility uses pre-agreed data sources to inform when conditions in contingent commitments are triggered.

The Financial Clearing Facility uses smart contracts to trigger financial transactions when relevant secondary contingent commitments have been demonstrably met.

Combination therapies will fundamentally change the paradigm for drug commercialization. Companies will need to take a more sophisticated approach to their pricing and reimbursement strategies… capable of factoring in the impact of a significant number of variables including major unknowns… The stakes and cost of getting it wrong are rising.
— David Greber and Srikant Vaidyanathan, Challenge of Pricing Combination Therapies, 
 BCG Perspectives, 2014